Cell Generation - About the company
Cell Generation is an unfunded company based in Israel, founded in 2019. It operates as a Provider of human mononuclear cells and plasma for research applications. Cell Generation has not raised any funding yet. The company has 995 active competitors, including 47 funded and 98 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Enzo.
Company Details
Provider of human mononuclear cells and plasma for research applications. Offerings include peripheral blood mononuclear cells, leukopaks, and plasma collected from donors. Isolated cell products consist of stem cells, monocytes, B cells, T cells, natural killer cells, and neutrophils. These biological materials are processed and cryopreserved for use in clinical trials and laboratory studies. Documentation regarding product characteristics and handling protocols is supplied with materials to support scientific investigations.
Key Metrics
Sign up to download Cell Generation's company profile
Cell Generation's funding and investors
Cell Generation has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cell Generation's Competitors and alternates
Top competitors of Cell Generation include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of Cell Generation, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Abcam 1998, Cambridge (United Kingdom), Acquired | Developer of biological reagents for life science research | $78.8M | 76/100 | |
2nd | Meridian Bioscience 1976, Ohio (United States), Acquired | Molecular diagnostic device and kits | - | 65/100 | |
3rd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | 65/100 | |
4th | Huwel Life 2015, Hyderabad (India), Series A | Molecular diagnostic solutions and products for the healthcare industry | $5.74M | 59/100 | |
5th | Stem Cell Technologies 1993, Vancouver (Canada), Series A | Developer of cell culture media and ancillary reagents for life science research | $11.9M | 58/100 | |
6th | Cell culture reagents for stem cell research | $18.2M | 56/100 | ||
7th | Teknova 1996, Hollister (United States), Public | Provider of molecular biology research reagents and kits | - | 56/100 | |
8th | PL BioScience 2015, Aachen (Germany), Series A | Manufacturer of human platelet lysate products for cell culture applications | $13M | 55/100 | |
9th | Luminex 1995, Austin (United States), Acquired | Developer of instruments, reagents and kits for clinical diagnostics and life science research | - | 55/100 | |
10th | Firefly BioWorks 2009, Cambridge (United States), Acquired | Develops platform to allow multiplexed assays on standard laboratory instrumentation | $3.77M | 54/100 | |
1136th | ![]() Cell Generation 2019, Israel, Unfunded | Provider of human mononuclear cells and plasma for research applications | - | - | 16/100 |
Looking for more details on Cell Generation's competitors? Click here to see the top ones
Cell Generation's Investments and acquisitions
Cell Generation has made no investments or acquisitions yet.
Reports related to Cell Generation
Here is the latest report on Cell Generation's sector:
Are you a Founder ?
FAQs about Cell Generation
Explore our recently published companies
- Float Cargo - San Francisco based, 2025 founded, Unfunded company
- Sathfere - Faridabad based, 2025 founded, Unfunded company
- Life Apollo - 2025 founded, Unfunded company
- Ameena - Unfunded company
- ProfCore - Geleen based, 1998 founded, Unfunded company
- Post AI Pilot - 2025 founded, Unfunded company
